Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Isabelle Sermet‐Gaudelus, Frantz Foissac et al.|Clinical Pharmacokinetics|2024Cited by 10
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic FibrosisSophie Ramel, Frantz Foissac, Nathalie Stremler et al.|Clinical and Translational Science|2025Cited by 4